Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Schroeder

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
IEEE Transactions on Visualization and Computer Graphics|November 20, 2025
Understanding Aortic Dissection Hemodynamics: Evaluating Adapted Smoke Surfaces Against Streakline-Based TechniquesAaron Schroeder, Kai Ostendorf, Kathrin Baumler, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 24, 2024
Potential and challenges of clinical high-dimensional flow cytometry: A call to actionThomas Liechti, Iva Lelios, Aaron Schroeder, et al.
Cytometry. Part B, Clinical Cytometry|March 23, 2026
Establishing a flow cytometry-based tissue receptor occupancy assay for an anti-oncostatin M receptor beta subunit therapeutic candidate in inflammatory bowel diseaseDivya Jha, Hailey Garma, Sean Lear, et al.
Plos One|July 1, 2016
miR-34 miRNAs Regulate Cellular Senescence in Type II Alveolar Epithelial Cells of Patients with Idiopathic Pulmonary FibrosisSupparerk Disayabutr, Eun Kyung Kim, Seung-Ick Cha, et al.
Transplantation Direct|January 26, 2023
Obinutuzumab Effectively Depletes Key B-cell Subsets in Blood and Tissue in End-stage Renal Disease PatientsCary M Looney, Aaron Schroeder, Erica Tavares, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 2, 2019
Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplantRobert R Redfield, Stanley C Jordan, Stephan Busque, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
IEEE Transactions on Visualization and Computer Graphics|November 20, 2025
Understanding Aortic Dissection Hemodynamics: Evaluating Adapted Smoke Surfaces Against Streakline-Based TechniquesAaron Schroeder, Kai Ostendorf, Kathrin Baumler, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 24, 2024
Potential and challenges of clinical high-dimensional flow cytometry: A call to actionThomas Liechti, Iva Lelios, Aaron Schroeder, et al.
Cytometry. Part B, Clinical Cytometry|March 23, 2026
Establishing a flow cytometry-based tissue receptor occupancy assay for an anti-oncostatin M receptor beta subunit therapeutic candidate in inflammatory bowel diseaseDivya Jha, Hailey Garma, Sean Lear, et al.
Plos One|July 1, 2016
miR-34 miRNAs Regulate Cellular Senescence in Type II Alveolar Epithelial Cells of Patients with Idiopathic Pulmonary FibrosisSupparerk Disayabutr, Eun Kyung Kim, Seung-Ick Cha, et al.
Transplantation Direct|January 26, 2023
Obinutuzumab Effectively Depletes Key B-cell Subsets in Blood and Tissue in End-stage Renal Disease PatientsCary M Looney, Aaron Schroeder, Erica Tavares, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 2, 2019
Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplantRobert R Redfield, Stanley C Jordan, Stephan Busque, et al.
Pageof 1